• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:闫立新.左西孟旦在老年顽固收缩性心力衰竭患者中的疗效观察[J].药学研究,2017,36(7):420-422[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3835次   下载 2953次 本文二维码信息
码上扫一扫!
左西孟旦在老年顽固收缩性心力衰竭患者中的疗效观察
闫立新
字体:加大+|默认|缩小-
(莱芜市新汶矿业集团莱芜中心医院,山东 莱芜 271103)
摘要:
目的 分析左西孟旦对老年顽固收缩性心力衰竭患者的疗效。方法 对128例符合纳入标准的心力衰竭患者入院初期应用常规药物洗脱治疗1周,1周后选取其中38例顽固性心力衰竭患者,按随机化原则分为对照组和治疗组各19例,对照组继续给予常规治疗,而治疗组在常规治疗基础上加左西孟旦治疗。比较两组治疗效果。结果 治疗组NYHA、LVEF及NT-proBN与对照组比较显著改善,差异有统计学意义(P<0.05);对照组应用左西孟旦后无低血压、心律失常和过敏发生,患者耐受性良好。结论 左西孟旦对老年顽固收缩性心功能不全患者有明显的疗效,且有较好的安全性和耐受性。
关键词:  左西孟旦  老年 心力衰竭
DOI:10.13506/j.cnki.jpr.2017.07.014
基金项目:
出版日期:2017-07-25
Observation on the effect of levosimendan in elderly patients with refractory systolic heart failure
YAN Lixin
(Laiwu Central Hospital of Xinwen Mining Group,Laiwu 271103,China)
Abstract:
Objective To analyze the effect of levosimendan on elderly patients with refractory systolic heart failure.Methods A total of 128 patients with heart failure who met the inclusion criteria were treated with conventional drug eluting therapy for 1 weeks at the initial stage of admission.One week later,38 patients with intractable heart failure were selected.They were divided into control group and treatment group according to the principle of randomization,each with 19 cases.The control group continued to be given conventional treatment,while the treatment group was treated with levosimendan on the basis of conventional treatment.The therapeutic effects of the two groups were compared.Results Compared with the control group,NYHA,LVEF and NT-proBN of treatment group were significantly improved,and the difference was statistically significant (P<0.05).The control group received levosimendan without hypotension,arrhythmia and hypersensitivity, and the patients were well tolerated.Conclusion Levosimendan was effective in the treatment of elderly patients with refractory systolic heart failure,and had better safety and tolerability.
Key words:  Levosimendan  Elderly  Heart failure
今日访问量:2493    总访问量:55338936
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司